80459-30-9

Basic information

• Product Name: Benzene, 1,1',1''-[[3-(octadecyloxy)-2-(phenylmethoxy)propoxy]methylidyne]tris-, (R)-
• CAS NO: 80459-30-9
• Molecular Formula: C47H64O3
• Molecular Weight: 677.023
• Mol File: 80459-30-9.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Benzene, 1,1',1''-[[3-(octadecyloxy)-2-(phenylmethoxy)propoxy]methylidyne]tris-, (R)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzene, 1,1',1''-[[3-(octadecyloxy)-2-(phenylmethoxy)propoxy]methylidyne]tris-, (R)-(80459-30-9)
• EPA Substance Registry System: Benzene, 1,1',1''-[[3-(octadecyloxy)-2-(phenylmethoxy)propoxy]methylidyne]tris-, (R)-(80459-30-9)

Safety Data

• Hazardous Substances Data: 80459-30-9(Hazardous Substances Data)

Upstream product

• 38169-74-3 1-O-Octadecyl-3-O-trityl-sn-glycerin 
• 100-44-7 benzyl chloride 
• 83526-60-7 2-O-Acetyl-1-O-benzyl-3-O-octadecyl-sn-glycerin 
• 83526-52-7 3-O-Octadecyl-2-O-p-toluolsulfonyl-sn-glycerin 
• 83526-54-9 3-O-Octadecyl-1-O-p-toluolsulfonyl-sn-glycerin 
• 83537-01-3 (-)-1-O-octadecyl-2-O-acetyl-sn-glycerol 
• 83526-56-1 (S)-1,2-Epoxy-3-(octadecyloxy)propan 
• 83526-51-6 3-O-Octadecyl-2-O-p-toluolsulfonyl-3-O-trityl-sn-glycerin 
• 83526-50-5 3-O-Octadecyl-1,2-di-O-p-toluolsulfonyl-sn-glycerin 
• 83526-57-2 (S)-1-(benzyloxy)-3-(octadecyloxy)propan-2-ol 
• 83167-57-1 3-O-Benzyl-1-O-octadecyl-sn-glycerol 
• 83526-53-8 (R)-1,2-Epoxy-3-(octadecyloxy)propan 
• 76-83-5 trityl chloride 
• 6076-32-0 3-O-Octadecyl-1-O-trityl-sn-glycerin 

Downstream Products

• 80483-86-9 2-O-Benzyl-1-O-octadecyl-sn-glycero-3-phosphorylcholin 
• 74430-89-0 Lyso-platelet-activating factor (C₁₈) 
• 105415-93-8 (R)-2-benzyloxy-3-octadecyloxypropyl 2-(N-methylpyrrolidinio)ethyl phosphate 
• 105435-57-2 (R)-2-benzyloxy-3-octadecyloxypropyl 2-(diethylmethylammonio)ethyl phosphate 
• 80707-93-3 (S)-1-O-octadecyl-2-O-benzyl-glycerol 

Relevant articles and documents

Chiral PAF agonists: Synthesis, theoretical analysis of their stereoelectronic properties and structure activity relationships

A series of chiral PAF agonists were synthesized. Modifications at the PAF structure were undertaken as far as the C2 substituents and the onium head groups are concerned. In parallel, molecular modelling studies including a MOPAC geometry optimization and the analysis of the electrostatic potential were performed on the newly synthesized and on already known PAF agonists, in order to gain a better insight into the stereoelectronic features required for interaction with the PAF receptor.